AGP Ltd (AGPL)

Karachi
110.72
-2.93(-2.58%)
  • Volume:
    266,800
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    109.40 - 115.00
  • Type:Equity
  • Market:Pakistan
  • ISIN:PK0113801010
  • S/N:AGP

AGPL Overview

Prev. Close
113.65
Day's Range
109.4-115
Revenue
7.42B
Open
114
52 wk Range
96.25-158.99
EPS
5.74
Volume
266,800
Market Cap
31B
Dividend (Yield)
2.00
(1.76%)
Average Volume (3m)
510,795
P/E Ratio
19.30
Beta
-
1-Year Change
6.53%
Shares Outstanding
280,000,000
Next Earnings Date
01 Dec 2021
What is your sentiment on AGP Ltd?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

AGP Ltd Company Profile

AGP Ltd Company Profile

Employees
1334
Market
Pakistan

AGP Limited manufactures, markets, and sells pharmaceutical and healthcare products under licensing arrangements in Pakistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, biguanide and S-urea combs, bile stone therapy, calcium, calcium channel blocker, cephalosporins oral and inject, Xa inhibitors, DPP-IV Inh and biguanide comb, DPP-IV Inh A-diab plain, expectorants, eye tonics and eye vitamins, fluoroquinolones, glitazone and biguanide combinations, hepatitis C antivirals, iron combination products, macrolides, muscle relaxants central, narcotic analgesic, and non-narcotic analgesic. It also provides oral fluoroquinolones, Oth folic acid, stomach disorder products, proton pump inhibitor, SSRI antidepressants, sulphonylurea vaso protectives, tonic, topical antihaemorrhoidal, urinary anti-infectives, urinary incontinence prd, vitamin B12, vitamin D3, and xanthine-systemic products. The company was founded in 1989 and is headquartered in Karachi, Pakistan.

Read More
  • why last day 10% decrease
    0
    • forcing indivduals to sale the stocks...this will pick the pace as soon as the q2 results will. e announced as well as any positive news associated with Russian vaccine
      0
    • sell it if it goes below 118.68 otherwise it is recommended to buy currently...
      0
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.